Notably, in bladder cancer the frequency of FGFR3 overexpression is much higher than the frequency of FGFR3 mutations, indicating that in HPV+ HNSCC more tumors may be affected than can be found in a mutational analysis [39]. This evidence concerns the gene FGFR3 and urinary bladder cancer.